Global dimensions of the AIDS epidemic: implications for prevention and care (Q34122337)

31 July 2017

1 reference

title

Global dimensions of the AIDS epidemic: implications for prevention and care (English)

1 reference

31 July 2017

1 reference

Dayton JM

1

1 reference

31 July 2017

Merson MH

series ordinal

2

1 reference

31 July 2017

language of work or name

1 reference

1 December 2000

1 reference

Infectious Disease Clinics of North America

31 July 2017

published in

1 reference

31 July 2017

volume

14

1 reference

31 July 2017

issue

4

1 reference

31 July 2017

page(s)

791-808

1 reference

Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970134-3

7 January 2021

Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970134-3

7 January 2021

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970134-3

7 January 2021

Influence of infant-feeding patterns on early mother-to-child transmission of HIV-1 in Durban, South Africa: a prospective cohort study. South African Vitamin A Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970134-3

7 January 2021

6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study G

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970134-3

7 January 2021

The HIV/AIDS epidemic in eastern Europe: recent patterns and trends and their implications for policy-making

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970134-3

7 January 2021

The AIDS epidemic--considerations for the 21st century

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970134-3

7 January 2021

Behavioral interventions for reduction of sexually transmitted disease/HIV transmission among female commercial sex workers and clients in Bali, Indonesia.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970134-3

7 January 2021

When is breastfeeding not best? The dilemma facing HIV-infected women in resource-poor settings.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970134-3

7 January 2021

The associations between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970134-3

7 January 2021

Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970134-3

7 January 2021

Complications after caesarean section in HIV-1-infected women not taking antiretroviral treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970134-3

7 January 2021

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970134-3

7 January 2021

Male circumcision and HIV infection: 10 years and counting

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970134-3

7 January 2021

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970134-3

7 January 2021

A community trial of the impact of improved sexually transmitted disease treatment on the HIV epidemic in rural Tanzania: 1. Design

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970134-3

7 January 2021

Progress and problems in the fight against AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970134-3

7 January 2021

Preventing HIV infection: lessons from Mwanza and Rakai

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970134-3

7 January 2021

Community-level interventions are needed to prevent new HIV infections

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970134-3

7 January 2021

Age of male circumcision and risk of prevalent HIV infection in rural Uganda.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970134-3

7 January 2021

Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970134-3

7 January 2021

Transmission dynamics of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970134-3

7 January 2021

Improved treatment services significantly reduce the prevalence of sexually transmitted diseases in rural Tanzania: results of a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970134-3

7 January 2021

HIV transmission through breastfeeding: a study in Malawi

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970134-3

7 January 2021

Short-course zidovudine for prevention of perinatal infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970134-3

7 January 2021

Bridge populations in the spread of HIV/AIDS in Thailand.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970134-3

7 January 2021

Two-year HIV-1-associated mortality in a Ugandan rural population

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970134-3

7 January 2021

HIV and AIDS in southeast Asia.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970134-3

7 January 2021

Primary HIV-1 resistance: a new phase in the epidemic?

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970134-3

7 January 2021

Proportion of HIV infections attributable to other sexually transmitted diseases in a rural Ugandan population: simulation model estimates

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970134-3

7 January 2021

Sexual transmission of HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970134-3

7 January 2021

Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970134-3

7 January 2021

Prophylactic cesarean delivery for the prevention of perinatal human immunodeficiency virus transmission: the case for restraint

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970134-3

7 January 2021

Epidemics of syphilis in the Russian Federation: trends, origins, and priorities for control

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970134-3

7 January 2021

Public Health Implications of Antiretroviral Therapy and HIV Drug Resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970134-3

7 January 2021

Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970134-3

7 January 2021

Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970134-3

7 January 2021

10.1016/S0891-5520(05)70134-3

Identifiers

DOI

1 reference

31 July 2017

1 reference